Evidence map›Paper›PMID 31192169›Full record

ArticleFrontiers in cellular and infection microbiology2019

Zinc and Iron Homeostasis: Target-Based Drug Screening as New Route for Antifungal Drug Development.

Claudia Simm, Robin C May

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Calcitermin-Loaded Smart Gels Activity againstGels (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Antifungal Drug Repurposing.Antibiotics (Basel, Switzerland) · 2020
    Article
  13. Review
  14. Article
  15. Potential of Gallium as an Antifungal Agent.Frontiers in cellular and infection microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Claudia SimmSchool of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Robin C MaySchool of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
University of Birmingham · GB

Funding

Medical Research Council MR/J008176/1
6 · The paper itself

Abstract

The incidence of fungal diseases is on the rise and the number of fatalities is still unacceptably high. While advances into antifungal drug development have been made there remains an urgent need to develop novel antifungal agents targeting as-yet unexploited pathways, such as metal ion homeostasis. Here we report such an approach by developing a metal sensor screen in the opportunistic human fungal pathogen

Indexed as

Drug DevelopmentHomeostasisA549 CellsAntifungal AgentsArtemisininsCandida albicansCandidiasisDrug Evaluation, PreclinicalHigh-Throughput Screening AssaysHumansIronMacrophagesMetalsMicrobial Sensitivity TestsMycosesPhagocytosisAntifungal AgentsartemisininArtemisininsIronMetalspyrviniumPyrvinium CompoundsSmall Molecule LibrariesZincantifungalsartemisininCandidahigh throughput drug screeningiron homeostasispyrvinium pamoatezinc homeostasis

Identifiers

PMID31192169
PMCPMC6548825
OpenAlexW2945540290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.